| Nadim A Geloo, MD | |
|
2901 Telestar Ct., #200, Falls Church, VA 22042-1262 | |
| (703) 573-3494 | |
| (703) 573-5353 |
| Full Name | Nadim A Geloo |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Interventional Cardiology |
| Location | 2901 Telestar Ct., Falls Church, Virginia |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1467432146 | NPI | - | NPPES |
| 1467432146 | Medicaid | VA |
| Entity Name | Harrisonburg Medical Associates |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1730146002 PECOS PAC ID: 8325030711 Enrollment ID: O20040402001310 |
News Archive
Two methods that permit scientists to examine critical stages in early embryogenesis are featured in this month's release of Cold Spring Harbor Protocols.
Advanced BioMedical Technologies Inc. announced that it has completed all 60 human clinical test cases of its PA Absorbable Orthopaedic Implant Screw according to the regulations set out by the China State Food and Drug Administration (SFDA). The actual number of test cases that have been taken in is 63.
e-Therapeutics plc today announces that recruitment of patients into both of the ongoing phase I trials of ETS2101 has been halted temporarily because of a practical issue with stored drug for the trials.
Exelixis, Inc. and Bristol-Myers Squibb Company today reported updated phase 2 clinical data which show that XL184 demonstrated activity in patients with glioblastoma multiforme (GBM), the most common and aggressive form of brain cancer.
› Verified 5 days ago
| Entity Name | Inova Health Care Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952320061 PECOS PAC ID: 2466351093 Enrollment ID: O20080806000696 |
News Archive
Two methods that permit scientists to examine critical stages in early embryogenesis are featured in this month's release of Cold Spring Harbor Protocols.
Advanced BioMedical Technologies Inc. announced that it has completed all 60 human clinical test cases of its PA Absorbable Orthopaedic Implant Screw according to the regulations set out by the China State Food and Drug Administration (SFDA). The actual number of test cases that have been taken in is 63.
e-Therapeutics plc today announces that recruitment of patients into both of the ongoing phase I trials of ETS2101 has been halted temporarily because of a practical issue with stored drug for the trials.
Exelixis, Inc. and Bristol-Myers Squibb Company today reported updated phase 2 clinical data which show that XL184 demonstrated activity in patients with glioblastoma multiforme (GBM), the most common and aggressive form of brain cancer.
› Verified 5 days ago
| Entity Name | Privia Medical Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013042480 PECOS PAC ID: 4385682061 Enrollment ID: O20140603000011 |
News Archive
Two methods that permit scientists to examine critical stages in early embryogenesis are featured in this month's release of Cold Spring Harbor Protocols.
Advanced BioMedical Technologies Inc. announced that it has completed all 60 human clinical test cases of its PA Absorbable Orthopaedic Implant Screw according to the regulations set out by the China State Food and Drug Administration (SFDA). The actual number of test cases that have been taken in is 63.
e-Therapeutics plc today announces that recruitment of patients into both of the ongoing phase I trials of ETS2101 has been halted temporarily because of a practical issue with stored drug for the trials.
Exelixis, Inc. and Bristol-Myers Squibb Company today reported updated phase 2 clinical data which show that XL184 demonstrated activity in patients with glioblastoma multiforme (GBM), the most common and aggressive form of brain cancer.
› Verified 5 days ago
| Entity Name | Northern Virginia Community Hospital, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669923967 PECOS PAC ID: 2567351760 Enrollment ID: O20170731003305 |
News Archive
Two methods that permit scientists to examine critical stages in early embryogenesis are featured in this month's release of Cold Spring Harbor Protocols.
Advanced BioMedical Technologies Inc. announced that it has completed all 60 human clinical test cases of its PA Absorbable Orthopaedic Implant Screw according to the regulations set out by the China State Food and Drug Administration (SFDA). The actual number of test cases that have been taken in is 63.
e-Therapeutics plc today announces that recruitment of patients into both of the ongoing phase I trials of ETS2101 has been halted temporarily because of a practical issue with stored drug for the trials.
Exelixis, Inc. and Bristol-Myers Squibb Company today reported updated phase 2 clinical data which show that XL184 demonstrated activity in patients with glioblastoma multiforme (GBM), the most common and aggressive form of brain cancer.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Nadim A Geloo, MD 2901 Telestar Ct., #300, Falls Church, VA 22042-1263 Ph: (703) 591-1688 | Nadim A Geloo, MD 2901 Telestar Ct., #200, Falls Church, VA 22042-1262 Ph: (703) 573-3494 |
News Archive
Two methods that permit scientists to examine critical stages in early embryogenesis are featured in this month's release of Cold Spring Harbor Protocols.
Advanced BioMedical Technologies Inc. announced that it has completed all 60 human clinical test cases of its PA Absorbable Orthopaedic Implant Screw according to the regulations set out by the China State Food and Drug Administration (SFDA). The actual number of test cases that have been taken in is 63.
e-Therapeutics plc today announces that recruitment of patients into both of the ongoing phase I trials of ETS2101 has been halted temporarily because of a practical issue with stored drug for the trials.
Exelixis, Inc. and Bristol-Myers Squibb Company today reported updated phase 2 clinical data which show that XL184 demonstrated activity in patients with glioblastoma multiforme (GBM), the most common and aggressive form of brain cancer.
› Verified 5 days ago
Amita Rajani, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 3300 Gallows Road Inova Fairfax Medical Campus, Department Of Medicine, Npt-2, Falls Church, VA 22042 Phone: 703-776-7780 | |
Dr. Mary Beck O'donnell, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 2960 Sleepy Hollow Rd, Falls Church, VA 22044 Phone: 703-536-2000 Fax: 703-536-4256 | |
Lindsey A. Cilia, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2901 Telestar Ct Ste 200, Falls Church, VA 22042 Phone: 703-573-3494 Fax: 703-573-5353 | |
Chin Hee Kim, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 3300 Gallows Rd Dept Of, Falls Church, VA 22042 Phone: 703-776-3582 | |
Candyce Heather Greene, MD, MPH, MSW Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 3300 Gallows Rd, Falls Church, VA 22042 Phone: 703-776-4001 Fax: 703-776-7113 | |
Dr. Megan Elizabeth Terek, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 3300 Gallows Rd, Falls Church, VA 22042 Phone: 703-776-4001 Fax: 703-776-7113 | |
Dr. Hazim El-haddad, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2901 Telestar Ct Ste 200, Falls Church, VA 22042 Phone: 703-573-3494 Fax: 703-573-5353 |